49 related articles for article (PubMed ID: 20653424)
1. Levels of HIV1 gp120 3D B-cell epitopes mutability and variability: searching for possible vaccine epitopes.
Khrustalev VV
Immunol Invest; 2010; 39(6):551-69. PubMed ID: 20653424
[TBL] [Abstract][Full Text] [Related]
2. Mutational pressure makes HIV1 gp120 linear B-cell epitopes shorter and may lead to their disappearance.
Khrustalev VV
Mol Immunol; 2010 Apr; 47(7-8):1635-9. PubMed ID: 20129670
[TBL] [Abstract][Full Text] [Related]
3. HIV1 V3 loop hypermutability is enhanced by the guanine usage bias in the part of env gene coding for it.
Khrustalev VV
In Silico Biol; 2009; 9(4):255-69. PubMed ID: 20109155
[TBL] [Abstract][Full Text] [Related]
4. Distribution of linear antigenic epitopes on GP120 encoded in sibling clones of novel New York HIV-1 subtype B isolates.
Riley JP; Pestano GA; Harewood K; Alfred LJ; Guyden J; Boto WM
Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S83-91. PubMed ID: 8574151
[TBL] [Abstract][Full Text] [Related]
5. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
[TBL] [Abstract][Full Text] [Related]
6. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
7. A region of the third variable loop of HIV-1 gp120 is recognized by HLA-B7-restricted CTLs from two acute seroconversion patients.
Safrit JT; Lee AY; Andrews CA; Koup RA
J Immunol; 1994 Oct; 153(8):3822-30. PubMed ID: 7523505
[TBL] [Abstract][Full Text] [Related]
8. [Molecular analysis of the principal neutralization epitope (V3 loop) of human immunodeficiency virus type 1 in Argentina].
Gómez Carrillo M; Piccardo C; Libonatti O
Rev Argent Microbiol; 1992; 24(2):91-101. PubMed ID: 1298019
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of diagnostic efficiency of the recombinant protein modeling immunodominant epitope V3 of envelope gp120 for immunoenzyme detection for HIV-1 infection antibodies].
Riabinina SA; Baranova EN; Sharipova IN; Susekina MI; Puzyrev VF; Obriadina AP; Burkov AN; Ulanova TI
Mol Gen Mikrobiol Virusol; 2007; (3):33-6. PubMed ID: 17886471
[TBL] [Abstract][Full Text] [Related]
10. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
11. Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine.
De Groot AS; Bishop EA; Khan B; Lally M; Marcon L; Franco J; Mayer KH; Carpenter CC; Martin W
Methods; 2004 Dec; 34(4):476-87. PubMed ID: 15542374
[TBL] [Abstract][Full Text] [Related]
12. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120.
Greenstein JL; Schad VC; Goodwin WH; Brauer AB; Bollinger BK; Chin RD; Kuo MC
J Immunol; 1992 Jun; 148(12):3970-7. PubMed ID: 1376346
[TBL] [Abstract][Full Text] [Related]
13. Percent of highly immunogenic amino acid residues forming B-cell epitopes is higher in homologous proteins encoded by GC-rich genes.
Khrustalev VV; Barkovsky EV
J Theor Biol; 2011 Aug; 282(1):71-9. PubMed ID: 21616083
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha.
Lekutis C; Shiver JW; Liu MA; Letvin NL
J Immunol; 1997 May; 158(9):4471-7. PubMed ID: 9127013
[TBL] [Abstract][Full Text] [Related]
15. Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france.
Damond F; Apetrei C; Robertson DL; Souquière S; Leprêtre A; Matheron S; Plantier JC; Brun-Vézinet F; Simon F
Virology; 2001 Feb; 280(1):19-30. PubMed ID: 11162815
[TBL] [Abstract][Full Text] [Related]
16. Can mutational GC-pressure create new linear B-cell epitopes in herpes simplex virus type 1 glycoprotein B?
Khrustalev VV
Immunol Invest; 2009; 38(7):613-23. PubMed ID: 19811425
[TBL] [Abstract][Full Text] [Related]
17. Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved.
Wiehe K; Easterhoff D; Luo K; Nicely NI; Bradley T; Jaeger FH; Dennison SM; Zhang R; Lloyd KE; Stolarchuk C; Parks R; Sutherland LL; Scearce RM; Morris L; Kaewkungwal J; Nitayaphan S; Pitisuttithum P; Rerks-Ngarm S; Sinangil F; Phogat S; Michael NL; Kim JH; Kelsoe G; Montefiori DC; Tomaras GD; Bonsignori M; Santra S; Kepler TB; Alam SM; Moody MA; Liao HX; Haynes BF
Immunity; 2014 Dec; 41(6):909-18. PubMed ID: 25526306
[TBL] [Abstract][Full Text] [Related]
18. Two B cell epitopes of HIV-1 Tat protein have limited antigenic polymorphism in geographically diverse HIV-1 strains.
Goldstein G; Tribbick G; Manson K
Vaccine; 2001 Feb; 19(13-14):1738-46. PubMed ID: 11166899
[TBL] [Abstract][Full Text] [Related]
19. Searching and mapping of B-cell epitopes in Bcipep database.
Saha S; Raghava GP
Methods Mol Biol; 2007; 409():113-24. PubMed ID: 18449995
[TBL] [Abstract][Full Text] [Related]
20. Reevaluation of amino acid variability of the human immunodeficiency virus type 1 gp120 envelope glycoprotein and prediction of new discontinuous epitopes.
Yamaguchi-Kabata Y; Gojobori T
J Virol; 2000 May; 74(9):4335-50. PubMed ID: 10756049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
